First Time Loading...

Anebulo Pharmaceuticals Inc
NASDAQ:ANEB

Watchlist Manager
Anebulo Pharmaceuticals Inc Logo
Anebulo Pharmaceuticals Inc
NASDAQ:ANEB
Watchlist
Price: 2.7036 USD -3.25% Market Closed
Updated: Apr 29, 2024

Anebulo Pharmaceuticals Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Anebulo Pharmaceuticals Inc
Cash from Financing Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Anebulo Pharmaceuticals Inc
NASDAQ:ANEB
Cash from Financing Activities
$6.4m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Financing Activities
-$15.8B
CAGR 3-Years
-32%
CAGR 5-Years
3%
CAGR 10-Years
-7%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Financing Activities
-$9.4B
CAGR 3-Years
-101%
CAGR 5-Years
-22%
CAGR 10-Years
-24%
Pfizer Inc
NYSE:PFE
Cash from Financing Activities
$26.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Cash from Financing Activities
-$4.8B
CAGR 3-Years
-19%
CAGR 5-Years
18%
CAGR 10-Years
2%
Eli Lilly and Co
NYSE:LLY
Cash from Financing Activities
$3.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Anebulo Pharmaceuticals Inc's Cash from Financing Activities?
Cash from Financing Activities
6.4m USD

Based on the financial report for Jun 30, 2023, Anebulo Pharmaceuticals Inc's Cash from Financing Activities amounts to 6.4m USD.

What is Anebulo Pharmaceuticals Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
26%

The average annual Cash from Financing Activities growth rates for Anebulo Pharmaceuticals Inc have been 26% over the past three years .